
Brenda Libby Coleman
Examiner (ID: 16325)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 338053
[patent_doc_number] => 07504394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-17
[patent_title] => 'Bazedoxifene ascorbate'
[patent_app_type] => utility
[patent_app_number] => 11/100902
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5866
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/504/07504394.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100902
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100902 | Bazedoxifene ascorbate | Apr 6, 2005 | Issued |
Array
(
[id] => 4797893
[patent_doc_number] => 20080009479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Tetrahydrobenzazepines as Histamine H3 Receptor Ligands'
[patent_app_type] => utility
[patent_app_number] => 10/599636
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14918
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599636 | Tetrahydrobenzazepines as Histamine H3 Receptor Ligands | Apr 5, 2005 | Abandoned |
Array
(
[id] => 7046167
[patent_doc_number] => 20050250762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Crystalline polymorph of bazedoxifene acetate'
[patent_app_type] => utility
[patent_app_number] => 11/100998
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6523
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250762.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100998
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100998 | Crystalline polymorph of bazedoxifene acetate | Apr 5, 2005 | Issued |
Array
(
[id] => 151669
[patent_doc_number] => 07683051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-23
[patent_title] => 'Crystalline polymorph of bazedoxifene acetate'
[patent_app_type] => utility
[patent_app_number] => 11/100983
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6735
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/683/07683051.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100983
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100983 | Crystalline polymorph of bazedoxifene acetate | Apr 5, 2005 | Issued |
Array
(
[id] => 4792715
[patent_doc_number] => 20080293689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Compounds with Atypical Antipsychotic Activity'
[patent_app_type] => utility
[patent_app_number] => 11/578113
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7012
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578113 | Compounds with Atypical Antipsychotic Activity | Apr 4, 2005 | Abandoned |
Array
(
[id] => 577861
[patent_doc_number] => 07456171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-25
[patent_title] => '1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/098670
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6392
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/456/07456171.pdf
[firstpage_image] =>[orig_patent_app_number] => 11098670
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/098670 | 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof | Apr 3, 2005 | Issued |
Array
(
[id] => 6931765
[patent_doc_number] => 20050282800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof'
[patent_app_type] => utility
[patent_app_number] => 11/096756
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16501
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282800.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096756 | Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof | Mar 30, 2005 | Abandoned |
Array
(
[id] => 7051499
[patent_doc_number] => 20050187386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)'
[patent_app_type] => utility
[patent_app_number] => 11/088058
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20127
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187386.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088058
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088058 | Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) | Mar 22, 2005 | Issued |
Array
(
[id] => 4753481
[patent_doc_number] => 20080161557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Synthesis of 2-Methyl-4-(4-Methyl-1-Piperazinly)-10H-Thieno(2,3-B) (1,5) Benzodiazepine and Salts Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/598816
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10552
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598816
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598816 | Synthesis of 2-Methyl-4-(4-Methyl-1-Piperazinly)-10H-Thieno(2,3-B) (1,5) Benzodiazepine and Salts Thereof | Mar 16, 2005 | Abandoned |
Array
(
[id] => 5131606
[patent_doc_number] => 20070208003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA'
[patent_app_type] => utility
[patent_app_number] => 10/598686
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18684
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20070208003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598686
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598686 | COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA | Mar 16, 2005 | Abandoned |
Array
(
[id] => 876405
[patent_doc_number] => 07358239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/079606
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8825
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358239.pdf
[firstpage_image] =>[orig_patent_app_number] => 11079606
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/079606 | Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives | Mar 13, 2005 | Issued |
Array
(
[id] => 7174086
[patent_doc_number] => 20050203297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Process for the preparation of carboxamide compounds'
[patent_app_type] => utility
[patent_app_number] => 11/077723
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4004
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203297.pdf
[firstpage_image] =>[orig_patent_app_number] => 11077723
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/077723 | Process for the preparation of carboxamide compounds | Mar 10, 2005 | Issued |
Array
(
[id] => 4596519
[patent_doc_number] => 07982032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide'
[patent_app_type] => utility
[patent_app_number] => 10/598623
[patent_app_country] => US
[patent_app_date] => 2005-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1876
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/982/07982032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598623
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598623 | Process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide | Mar 9, 2005 | Issued |
Array
(
[id] => 5101827
[patent_doc_number] => 20070185089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Benzazepine derivatives for the treatment of neurological and psychiatric disorders'
[patent_app_type] => utility
[patent_app_number] => 10/598759
[patent_app_country] => US
[patent_app_date] => 2005-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27310
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598759 | Benzazepine derivatives for the treatment of neurological and psychiatric disorders | Mar 9, 2005 | Abandoned |
Array
(
[id] => 7075311
[patent_doc_number] => 20050148579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Process for preparing 6-aryl-4H-S-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepines'
[patent_app_type] => utility
[patent_app_number] => 11/074198
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3124
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074198
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074198 | Process for preparing 6-aryl-4H-S-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepines | Mar 6, 2005 | Abandoned |
Array
(
[id] => 5070246
[patent_doc_number] => 20070191348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Isopropanol water solvate of olanzapine'
[patent_app_type] => utility
[patent_app_number] => 10/591831
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5690
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191348.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591831 | Isopropanol water solvate of olanzapine | Mar 6, 2005 | Issued |
Array
(
[id] => 4786203
[patent_doc_number] => 20080139532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents)'
[patent_app_type] => utility
[patent_app_number] => 10/591782
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13006
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591782 | Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents) | Mar 3, 2005 | Abandoned |
Array
(
[id] => 4740830
[patent_doc_number] => 20080234483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Fasudil-Containing Preparation and Method of Improving Stability Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/598303
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4058
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234483.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598303 | Fasudil-containing preparation and method of improving stability thereof | Mar 3, 2005 | Issued |
Array
(
[id] => 7518929
[patent_doc_number] => 07973030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Benzothiazepine and benzothiepine compounds'
[patent_app_type] => utility
[patent_app_number] => 10/590458
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 326164
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/973/07973030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590458 | Benzothiazepine and benzothiepine compounds | Feb 24, 2005 | Issued |
Array
(
[id] => 7988051
[patent_doc_number] => 08076320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Crystalline forms of a pharmaceutical compound'
[patent_app_type] => utility
[patent_app_number] => 10/597977
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11430
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597977
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597977 | Crystalline forms of a pharmaceutical compound | Feb 23, 2005 | Issued |